Past funding

Technology Transfer has committed over £210 million to translational projects across 80 institutions and in excess of 50 companies. On aggregate, over £420m has been generated in third-party finance for these projects.

The types of project we support span computational chemistry to drug discovery, vaccine formulation and human proof-of-principle studies for medical devices, diagnostics and candidate pharmaceutical compositions. Therapeutic areas include cancer, the central nervous system, infectious diseases, inflammation, metabolism, tissue and wound healing.

The projects we have funded can be split broadly into the following areas:

• diagnostics
• enabling technology
• regenerative medicine
• therapeutics (including Seeding Drug Discovery)
• vaccine
• medical devices

Medical Engineering

In June 2009 the Wellcome Trust and the Engineering and Physical Sciences Research Council (EPSRC) formed a strategic partnership to stimulate the formation and support of world-class centres of excellence in medical engineering within the UK. The intent is that each centre will provide an environment for the integration of the various contributory disciplines, and encourage both exploratory research and the translation of that research into specific product developments of benefit to healthcare. Four awards with a combined total of £41m have now been made.